Janardan Nimbolkar

Janardan Nimbolkar

B

Profile ID RP-000-1598 Joined 2023-01-17 3 articles
0Connections
8
Total Views
3
Total Publications
48
Publication Views

Articles(3)

Authors: Shubha Chogle, Janardan Nimbolkar*, Lata Bhandarkar, Aruna Poojary, Ritu Chandel

DOI: 10.18231/j.ijcbr.2022.010

Volume9
Issue1
Pages53-58
Abstract

Introduction: Diabetic and hypertensive patients gradually gets decreased glomerular function. Creatinine starts rising and exhibits decreased kidney function when more than 50% of glomerular function is lost. Cystatin C, a parameter which accesses kidney function accurately predicts GFR. Materials and Methods: GFR is calculated by measuring Cystatin C and Creatinine. Groups were normal patients, diabetics patients, Comparison of changes of pre and post treatment GFR by Creatinine and Cystatin. Results: Total 57 patient studied 1) Cystatin C GFR is lower than creatinine GFR in 20 normal patients with P value with paired t test is 0.0032 hence prompts early renal evaluation whereas creatinine GFR overestimates renal function. 2) cystatin C GFR in 37 patients with kidney dysfunction and diabetes is less than Creatine GFR with p-value < 0 xss=removed> 0.05 but these patients high Creatinine levels on admission which gets normalised with remarkable rise in GFR whereas Cystatin C levels gets marginally decrease suggests renal recovery ongoing. Conclusions: Clearly exhibits Creatinine GFR is overestimates renal function. Patients with normal GFR by Creatinine having raised Cystatin C levels prompts early renal evaluation. Cystatin C is accurately estimating, less affected by variables and predicting severity of renal dysfunction. Thus, Cystatin C GFR better diagnostic and sensitive maker than creatinine GFR for accurate prediction of renal dysfunction in Diabetic patients.   Keywords: GFR, ESRD, AKI, Cystatin C, Creatinine.

Authors: Shubha Chogle, Janardan Nimbolkar*, Rittu Chandel, Aruna Poojary, Shubhra Kar

DOI: 10.18231/j.ijcbr.2022.005

Volume9
Issue1
Pages22-27
Abstract

Introduction: sST2 is a member of interleukin 1 receptor family biomarker and the concentration of its soluble isoform increases with cardiac stress leading to cardiac fibrosis. It has 2 isoforms the ligand forms sST2L and soluble form. In acute or chronic heart failure the soluble form is highly prognostic and predictive of mortality. Materials and Methods: It’s a prospective study of patients aged 45 to 90 with reduced ejection fraction and cardiomyopathy. Sample collected for day 1,5,30. There outcome assessed at day 30 and mortality on one year follow up. Results: Total 79 patients studied, 57 LVF cases and 22 healthy controls. 50 males, 29 females, Cardiomyopathy 24 cases. Mean sST2 value 137.7829±89 (SD). At 30 days outcome and one year mortality with significant P value 0.000. As the age increases sST2 levels rises. For cardiomyopathy patients sST2 (141±78). At day 5 and 30 patients improved with decrease in levels where worsened patients had persistent high values. Those patient with more than 250 or implausible values had worse outcome or expired. Most important those responded to appropriate treatment values significantly improved. For cardiomyopathy patients values remained high persistently and ultimately required cardiac transplant or definitive line of treatment. Conclusions: sST2 is diagnostic and prognostic marker in patients with HFrEF presenting as acute or chronic heart failure. Significant p values for 30 days outcome and mortality. In cardiomyopathy patients with persistent high levels were bad prognostic indicator and suggests consideration of definitive line of treatment.   Keywords: Heart failure, Biomarker, Interleukin, Cardiac, Prognosis.

Authors: Hemant Thacker, Janardan Nimbolkar, Bhavesh Gandhi

DOI: 10.18231/j.sajcrr.2021.005

Volume8
Issue1
Pages26-29
Abstract

Scleredema is a connective tissue disorder of unknown etiology. Case Report: A 44 years diabetic, obese female patient, admitted with edema feet, erythematous, indurated hyper pigmentation with ascending progression to trunk which rapidly transformed to painless dark pigmented blister and hard non-pitting edema of anterior abdominal wall. In a week time. She was managed with broad spectrum antibiotics, was aggressively diuresed along with albumin infusion. Her skin biopsy was done which revealed scleredema. She had poor LV function due to volume overload or cardiomyopathy. After initial improvement on 14 day, she suddenly developed fulminant septicemia. Within hours, she displayed multi organ dysfunction and the heart and kidney which were already delicately balanced, decompensated. There was intractable arrhythmias and severe LV dysfunction, renal failure and ischemic hepatitis following severe hypotension. Scleredema in diabetic subjects, can be an ominous sign for producing fulminant multiorgan dysfunction and can present as cardiomyopathy, myocarditis, liver dysfunction etc., and these patients are more prone to infections or may be vice versa. Scleredema can be considered as a marker of fulminant illness in immunocompromised individuals. There is a need for treatment protocols or research into this a rather enigmatic but rare illness. Keywords: Diabetic, Scleredema

No matching articles

Try another word from the title, author or DOI.

Brief Bio

No bio added yet.

Affiliations

Nothing added yet.

Education

Nothing added yet.

Honors & Awards

Nothing added yet.

Society Memberships

Nothing added yet.

Expertise

Nothing added yet.

Specialty

Nothing added yet.

Other Online Pages

Scholars in the same field

SN
Soumya Nayak
0 publications
MR
Manjunath R Kudari
0 publications
AK
Dr Anil Kumar Dwivedi
Veer Chandra Singh Garhwali Government Institute of Medical Science and Research, Srinagar Garhwal Uttarakhand, India
0 publications
NB
Nirjan Biswas
0 publications
PS
parimala subramani
0 publications
HP
Himanshu Pandey
0 publications
Dr Sameer Dileep Joshi
LNBCIEM Satara Maharashtra
0 publications
RS
R SANJAY
0 publications

Following

Nobody here yet.

Followers

Nobody here yet.

3 Publications